|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0051 | ED148934 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0088 | ED148286 | General Research Use | No | Female | White | 68 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0142 | ED148483 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 6 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0286 | ED149189 | General Research Use | No | Male | White | 69 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0297 | ED149322 | General Research Use | No | Female | White | 61 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0315 | ED149030 | General Research Use | No | Male | White | 82 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0403 | ED149705 | General Research Use | No | Female | White | 67 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0458 | ED149258 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0598 | ED148763 | General Research Use | No | Male | White | 80 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0670 | ED149522 | General Research Use | No | Female | White | 83 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0689 | ED149172 | General Research Use | No | Female | White | 78 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0708 | ED149923 | General Research Use | No | Male | White | 75 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_1046 | ED148331 | General Research Use | No | Female | White | 73 | 8 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1075 | ED148487 | General Research Use | No | Male | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1088 | ED148864 | General Research Use | No | Female | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1118 | ED149292 | General Research Use | No | Male | White | 67 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1139 | ED148131 | General Research Use | No | Female | White | 60 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1243 | ED149584 | General Research Use | No | Female | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1248 | ED148490 | General Research Use | No | Female | White | 70 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1249 | ED148570 | General Research Use | No | Female | White | 66 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |